GCP
IBB icon

GSA Capital Partners’s iShares Biotechnology ETF IBB Stock Holding History

GSA Capital Partners’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$472K Buy
+2,481
New +$426K 0.03% 1045
2026
Q1 		– Sell
-2,271
Closed -$383K – 1921
2025
Q4 		$383K Buy
+2,271
New +$369K 0.03% 1005

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

GSA Capital Partners's IBB Position: Q2 2026 in Review

GSA Capital Partners opened a new position in iShares Biotechnology ETF (IBB) in Q2 2026: 2,481 shares worth $472K. The stake represents 0.03% of the portfolio and ranks #1045 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in IBB as recently as Q4 2025.

GSA Capital Partners first reported a position in IBB in Q4 2025 and has held it in 2 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • GSA Capital Partners held 2,481 shares of iShares Biotechnology ETF worth $472K as of Q2 2026.
  • iShares Biotechnology ETF was a new GSA Capital Partners position in Q2 2026.
  • iShares Biotechnology ETF made up 0.03% of GSA Capital Partners's portfolio in Q2 2026, its #1045 holding.
  • GSA Capital Partners first reported a position in iShares Biotechnology ETF in Q4 2025 and has held it in 2 quarters since.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.